{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/06/3289301/0/en/New-2-Year-Data-from-Pivotal-ApproaCH-Trial-of-TransCon-CNP-Navepegritide-Show-Pronounced-Gains-in-Growth-Outcomes-in-Children-with-Achondroplasia-Aged-5-Years.html", "message": "News view counter 707550 successfully enlarged"}